Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Rubicon collaborates with OncoMethylome to identify cancer biomarkers

Rubicon Genomics : 23 January, 2008  (New Product)
Rubicon Genomics has entered into a collaboration agreement with OncoMethylome Sciences for the identification of biomarkers for early detection of cancer.
Rubicon plans to use its MethylPlex platform to carry out the marker identification analysis. As part of the agreement, Rubicon granted an option to OncoMethylome for licensing markers resulting from the collaboration. This is the second such marker identification agreement between the two companies, and OncoMethylome Sciences has already licensed a set of markers from Rubicon.

Cancer cells alter the normal patterns of DNA methylation giving the tumour the ability to grow and spread. The patterns of abnormal methylation in DNA are strong predictors of the presence of cancer as well as other diseases. MethylPlex is a method for identifying multi-gene patterns of abnormal DNA methylation during tumour formation and progression.

'We believe that detection of methylated DNA biomarkers is the most sensitive and specific method for early detection and characterisation of cancer,' said Fred Beyerlein, president and CEO of Rubicon Genomics. 'We are looking forward to again be working with OncoMethylome Sciences, a recognised leader in the field of methylation.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo